NP
Last reporting period 31 Mar, 2022
Updated —
Last price
—
Market cap $B
0
Exchange
OOTC - OTC
0.0
Last period Current ratio
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Neuropathix
Company Analysis
NPTX valuation, rating, competitors, insights and company profile
Eyestock Rating
NPTX financial analysis by Eyestock methodology
Valuation
NPTX valuation using historical relative method
Statements
NPTX Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NPTX dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Neuropathix`s Current ratio for the last twelve months ended 2022-03-31 is 0.0
